Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases

Brain metastases are the most severe tumorous spread during breast cancer disease. They are associated with a limited quality of life and a very poor overall survival. A subtype of extracellular vesicles, exosomes, are sequestered by all kinds of cells, including tumor cells, and play a role in cell...

Full description

Bibliographic Details
Main Authors: Carolin J. Curtaz, Leonie Reifschläger, Linus Strähle, Jonas Feldheim, Julia J. Feldheim, Constanze Schmitt, Matthias Kiesel, Saskia-Laureen Herbert, Achim Wöckel, Patrick Meybohm, Malgorzata Burek
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/7/3683
_version_ 1797439033116196864
author Carolin J. Curtaz
Leonie Reifschläger
Linus Strähle
Jonas Feldheim
Julia J. Feldheim
Constanze Schmitt
Matthias Kiesel
Saskia-Laureen Herbert
Achim Wöckel
Patrick Meybohm
Malgorzata Burek
author_facet Carolin J. Curtaz
Leonie Reifschläger
Linus Strähle
Jonas Feldheim
Julia J. Feldheim
Constanze Schmitt
Matthias Kiesel
Saskia-Laureen Herbert
Achim Wöckel
Patrick Meybohm
Malgorzata Burek
author_sort Carolin J. Curtaz
collection DOAJ
description Brain metastases are the most severe tumorous spread during breast cancer disease. They are associated with a limited quality of life and a very poor overall survival. A subtype of extracellular vesicles, exosomes, are sequestered by all kinds of cells, including tumor cells, and play a role in cell-cell communication. Exosomes contain, among others, microRNAs (miRs). Exosomes can be taken up by other cells in the body, and their active molecules can affect the cellular process in target cells. Tumor-secreted exosomes can affect the integrity of the blood-brain barrier (BBB) and have an impact on brain metastases forming. Serum samples from healthy donors, breast cancer patients with primary tumors, or with brain, bone, or visceral metastases were used to isolate exosomes and exosomal miRs. Exosomes expressed exosomal markers CD63 and CD9, and their amount did not vary significantly between groups, as shown by Western blot and ELISA. The selected 48 miRs were detected using real-time PCR. Area under the receiver-operating characteristic curve (AUC) was used to evaluate the diagnostic accuracy. We identified two miRs with the potential to serve as prognostic markers for brain metastases. Hsa-miR-576-3p was significantly upregulated, and hsa-miR-130a-3p was significantly downregulated in exosomes from breast cancer patients with cerebral metastases with AUC: 0.705 and 0.699, respectively. Furthermore, correlation of miR levels with tumor markers revealed that hsa-miR-340-5p levels were significantly correlated with the percentage of Ki67-positive tumor cells, while hsa-miR-342-3p levels were inversely correlated with tumor staging. Analysis of the expression levels of miRs in serum exosomes from breast cancer patients has the potential to identify new, non-invasive, blood-borne prognostic molecular markers to predict the potential for brain metastasis in breast cancer. Additional functional analyzes and careful validation of the identified markers are required before their potential future diagnostic use.
first_indexed 2024-03-09T11:46:58Z
format Article
id doaj.art-eb129504929c48f589fe776df757f2c2
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T11:46:58Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-eb129504929c48f589fe776df757f2c22023-11-30T23:20:33ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-03-01237368310.3390/ijms23073683Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain MetastasesCarolin J. Curtaz0Leonie Reifschläger1Linus Strähle2Jonas Feldheim3Julia J. Feldheim4Constanze Schmitt5Matthias Kiesel6Saskia-Laureen Herbert7Achim Wöckel8Patrick Meybohm9Malgorzata Burek10Department of Gynecology and Obsterics, University Hospital Würzburg, 97080 Würzburg, GermanyDepartment of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, 97080 Würzburg, GermanyDepartment of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, 97080 Würzburg, GermanyCenter for Translational Neuro- and Behavioral Sciences, University Hospital Essen, 45147 Essen, GermanyDepartment of Neurosurgery, University Hospital Essen, 45147 Essen, GermanyDepartment of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, 97080 Würzburg, GermanyDepartment of Gynecology and Obsterics, University Hospital Würzburg, 97080 Würzburg, GermanyDepartment of Gynecology and Obsterics, University Hospital Würzburg, 97080 Würzburg, GermanyDepartment of Gynecology and Obsterics, University Hospital Würzburg, 97080 Würzburg, GermanyDepartment of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, 97080 Würzburg, GermanyDepartment of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, 97080 Würzburg, GermanyBrain metastases are the most severe tumorous spread during breast cancer disease. They are associated with a limited quality of life and a very poor overall survival. A subtype of extracellular vesicles, exosomes, are sequestered by all kinds of cells, including tumor cells, and play a role in cell-cell communication. Exosomes contain, among others, microRNAs (miRs). Exosomes can be taken up by other cells in the body, and their active molecules can affect the cellular process in target cells. Tumor-secreted exosomes can affect the integrity of the blood-brain barrier (BBB) and have an impact on brain metastases forming. Serum samples from healthy donors, breast cancer patients with primary tumors, or with brain, bone, or visceral metastases were used to isolate exosomes and exosomal miRs. Exosomes expressed exosomal markers CD63 and CD9, and their amount did not vary significantly between groups, as shown by Western blot and ELISA. The selected 48 miRs were detected using real-time PCR. Area under the receiver-operating characteristic curve (AUC) was used to evaluate the diagnostic accuracy. We identified two miRs with the potential to serve as prognostic markers for brain metastases. Hsa-miR-576-3p was significantly upregulated, and hsa-miR-130a-3p was significantly downregulated in exosomes from breast cancer patients with cerebral metastases with AUC: 0.705 and 0.699, respectively. Furthermore, correlation of miR levels with tumor markers revealed that hsa-miR-340-5p levels were significantly correlated with the percentage of Ki67-positive tumor cells, while hsa-miR-342-3p levels were inversely correlated with tumor staging. Analysis of the expression levels of miRs in serum exosomes from breast cancer patients has the potential to identify new, non-invasive, blood-borne prognostic molecular markers to predict the potential for brain metastasis in breast cancer. Additional functional analyzes and careful validation of the identified markers are required before their potential future diagnostic use.https://www.mdpi.com/1422-0067/23/7/3683breast cancerbreast cancer metastasesblood-brain barrierpatient serumexosomesmicroRNA
spellingShingle Carolin J. Curtaz
Leonie Reifschläger
Linus Strähle
Jonas Feldheim
Julia J. Feldheim
Constanze Schmitt
Matthias Kiesel
Saskia-Laureen Herbert
Achim Wöckel
Patrick Meybohm
Malgorzata Burek
Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases
International Journal of Molecular Sciences
breast cancer
breast cancer metastases
blood-brain barrier
patient serum
exosomes
microRNA
title Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases
title_full Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases
title_fullStr Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases
title_full_unstemmed Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases
title_short Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases
title_sort analysis of micrornas in exosomes of breast cancer patients in search of molecular prognostic factors in brain metastases
topic breast cancer
breast cancer metastases
blood-brain barrier
patient serum
exosomes
microRNA
url https://www.mdpi.com/1422-0067/23/7/3683
work_keys_str_mv AT carolinjcurtaz analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases
AT leoniereifschlager analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases
AT linusstrahle analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases
AT jonasfeldheim analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases
AT juliajfeldheim analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases
AT constanzeschmitt analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases
AT matthiaskiesel analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases
AT saskialaureenherbert analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases
AT achimwockel analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases
AT patrickmeybohm analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases
AT malgorzataburek analysisofmicrornasinexosomesofbreastcancerpatientsinsearchofmolecularprognosticfactorsinbrainmetastases